Bob Lederer PRVR

Google Genomics. Watson & genetics. Pharmacos: PROs, personalized med (PRVR 11.17.14)

To subscribe to PRVR and receive an email with multiple links to the latest video report, please click: http://ow.ly/Clawn

Pharma Research VIDEO Report, a co-partnered production with the Pharmaceutical Marketing Research Group, is sponsored this week by the Toluna Healthcare Practice, offering highly engaged physicians, health professionals and ailment sufferers for global research using cutting-edge methodologies, sophisticated, yet easy-to-use analytic tools and specialized products including Pharmacy Intercept, dedicated communities, patient record studies and more.

Find out about the Toluna Healthcare Practice at its homepage: http://www.toluna-group.com/about-toluna/industries-we-serve/healthcare/overview
On this PRVR:

1) Google Genomics plans to store individuals’ genomes in the cloud, where they can be analyzed en masse by healthcare researchers.
Link: http://bigthink.com/ideafeed/for-new-era-of-personalized-medicine-google-to-store-individual-genomes-in-the-cloud

2) The IBM Watson program has invested in Pathway Genomics, which will use Watson’s computing prowess to offer a consumer app that can provide answers to personal health questions.
Link: http://www.thestreet.com/story/12950769/1/how-ibm-and-watson-plan-to-use-your-genetic-code-to-help-you-live-longer.html

3) Except for Jannsen, Novartis and Roche, few of the top 12 pharmaceutical companies are commercially ready for a personalized medicine business model
Link: http://www.diaceutics.com/new-report-reveals-most-leading-pharma-companies-still-not-commercially-ready-personalized-medicine

4) Patient Reported Outcomes (PROs) are of interest to pharmaceutical companies in their marketing strategies, but they are not finding buy-in from regulatory agencies.
LInk: http://www.marketwired.com/press-release/drug-makers-report-average-22-patient-reported-outcomes-endpoints-appear-on-final-product-1966590.htm

5) Sentrian’s remote patient intelligence platform plans to spot individuals’ impending health problems before they require hospitalization.
Link: http://www.prnewswire.com/news-releases/sentrian-the-worlds-first-remote-patient-intelligence-company-launches-to-eliminate-preventable-hospitalization-282122331.html

Bob Lederer RFL Communications, Inc.

Using publicly available information sources, IARP aims to detect disease outbreaks early; Community colleges to boost med device training; wearable med devices have questionable health benefits; Dick Vanderveer notes two leading MR issues; Cutting Edge “Big Data” study (PMRVR 2/24/14)

PMR VIDEO Report is sponsored by M/A/R/C Research (http://www.marcresearch.com), which says “strong brands start with strong research.”

1) The Intelligence Advanced Research Projects Agency wants to use publicly available data to predict disease outbreaks early enough that administrators can take action to limit its spread. 2) The U.S. Labor Department is helping community colleges create curriculum and training programs to prepare individuals to work in medical device manufacturing and operations. 3) 90 million wearable devices will be shipped this year; medical, wellness and sports & activity devices will be the bulk of those. What’s the evidence that the health of users of these devices will benefit? 4) Dick Vanderveer has launched and sold three successful pharma MR companies. He suggests two significant changes that PMRVR and other media should be paying special attention to. 5) Cutting Edge Information’s new Cutting Edge Information report on Big Data says more than half of the Top 10 pharmaceutical companies have dedicated teams in place to explore and implement Big Data potential.